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Glycine-induced hyponatremia in the rat: A model of post-prostatec-
tomy syndrome. Post-prostatectomy syndrome (PPS) is characterized by
hyponatremia after absorption of glycine irrigant. To study the pathogen-
esis of this syndrome, adult male rats with ligated ureters were infused
over 15 minutes with 7.5 ml/100 g body weight of isosmotic glycine (N =
9) or mannitol (N = 9) and were compared to non-infused, ureter-ligated
controls (N = 9). Immediately post-infusion, plasma sodium had de-
creased similarly in glycine- and mannitol-infused animals (111 2 vs. 106
1 mmol/liter), but plasma osmolality remained at control levels in both
groups (285 1 vs. 288 1 mOsm/kg). Two hours post-infusion,
hyponatremia was stable in the mannitol group (108 1 mmol/liter), but
in the glycine group plasma sodium increased significantly (to 120 1
mmol/Iiter). Plasma osmolality two hours post-infusion was maintained in
both the glycine (287 2) and mannitol (292 2) groups. Brain water in
glycine-infused animals (3.90 0.01 liter/kg dry wt) was not significantly
different from the mannitol-infused group (3.85 0.01) and only 1.8%
higher than non-infused controls (3.83 0.02). Brain tissue glycine did not
differ between the three groups. In contrast, muscle water two hours
post-infusion in the glycine group was 6% higher than mannitol-infused
and 13% higher than non-infused animals. Muscle glycine content in the
glycine group (67 4 mM/kg dry tissue) was increased when compared to
both mannitol-infused (25 1) and non-infused (20 1) groups. Plasma
ammonia and brain glutamine were significantly increased in glycine-
infused animals. In a second set of studies, infusion of 7.5 ml/100 g body
weight of 1.5% (200 mmol/liter) glycine caused only a non-significant
increase in brain water. In conclusion, in a model of PPS in rats, acute
hyponatremia induced by intravenous isosmotic glycine did not decrease
plasma osmolality. Hyponatremia induced by isosmotic or hypoosmotic
glycine caused minimal brain edema.
The post-prostatectomy syndrome (PPS) is characterized by
neurologic deterioration due to massive systemic absorption of
irrigant during transurethral resection of the prostate (TURP).
Manifestations of PPS range from headache and visual distur-
bances to coma, seizures, and death. Hyponatremia develops
acutely, commonly to levels less than 120 mmol/liter, and corre-
lates with the severity of PPS and the amount of irrigant absorbed
[1, 21. As most reports of PPS are associated with glycine solution,
the most widely used irrigant for TURP, our study addresses the
significance of the acute hyponatremia associated with systemic
absorption of glycine [3].
It is widely presumed that the symptoms of PPS are due to
Received for publication February 24, 1994
and in revised form July 18, 1994
Accepted for publication July 21, 1994
© 1995 by the International Society of Nephrology
cerebral edema secondary to acute hyponatremia, and recommen-
dations for treatment commonly include use of hypertonic saline
[4, 51. However, when PPS is caused by glycine irrigant, plasma
osmolality remains normal or only slightly decreased despite
severe hyponatremia, and there is little evidence of brain swelling
by autopsy study [3]. Thus, effects of glycine absorption may be
due to toxicity of glycine and/or its metabolites.
Several studies have employed animal models of glycine-in-
duced PPS, but none have assessed changes in brain water and
solute [6—11]. In this study, we infused both isomotic and 200
mmol/liter glycine (the most widely used glycine solution in
practice) intravenously to rats, inducing hyponatremia to a degree
similar to that observed in patients with PPS. The results show
that hyponatremia caused by systemically-absorbed glycine is
associated with minimal brain swelling and should not be equated
with other causes of acute water intoxication.
Methods
Experiment 1
Twenty-seven male Sprague-Dawley rats (Holtzman Labs,
Madison, Wisconsin, USA) weighing 250 to 300 g were studied.
After a 12 hour fast, the animals were anesthetized with pento-
barbital (50 mg/kg i.p.). The femoral artery and vein were then
cannulated with PE 50. Sutures were placed loosely around both
ureters and were brought out of the abdomen. The animals were
allowed 90 minutes to recover from surgery and then both ureters
were ligated. Animals were studied by one of three protocols, with
nine animals in each group:
(1) Group I: Non-infused controls
(2) Group II: Mannitol-infused controls: 7.5 ml/100 g body weight
of 290 mOsm/kg intravenous mannitol given over 15 minutes
(3) Group III: Glycine-infused (model of PPS): 7.5 ml/100 g body
weight of 290 mOsm/kg intravenous glycine given over 15
minutes
In the mannitol- and glycine-infused groups, arterial blood
samples (2.5 ml) were obtained immediately after the infusion was
completed (one mm). Two hours after the infusion, a second
sample of arterial blood was obtained and animals were then
sacrificed by decapitation. Immediately after decapitation, the
head was cut sagitally with a scroll saw and within 15 seconds one
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hemisphere of the brain was placed in liquid nitrogen and stored
at —70°C. This brain hemisphere was later crushed under liquid
nitrogen and divided into aliquots for measurement of hemoglo-
bin, amino acids, urea, mannitol and glucose. The other half was
weighed, dried at 100°C for 48 hours, and reweighed to determine
water content. This half of the brain was then extracted in 0.75 N
HNO3 for determination of sodium and potassium. The gastroc-
nemius muscle was rapidly removed after decapitation, placed in
liquid nitrogen, and stored at —70°C. Later, the muscle sample
was crushed under liquid nitrogen. A large aliquot of this crushed
muscle tissue was weighed and dried at 100°C for 48 hours,
reweighed to determine water content, and then extracted in 0.75
N HNO3 for determination of sodium and potassium. The rest of
the crushed muscle tissue was divided into aliquots for measure-
ment of hemoglobin, amino acids, urea, mannitol and glucose.
One sample of arterial blood was obtained from non-infused
animals after ureteral ligation, followed by decapitation and tissue
removal as described above.
Experiment II
To more closely mimic systemic glycine absorption as it occurs
in clinical practice, an additional series of experiments was
performed. Animals were prepared as in Experiment I (with the
exception that no ureteral ligation was performed in Group III)
and studied by one of three protocols:
Group I (N = 8). Non-infused controls with ureteral ligation.
Group II (N = 8). Hypoosmotic glycine infused without ureteral
ligation; 7.5 ml/100 g body weight of 200 mmollliter intravenous
glycine given over 15 minutes.
Group III (N 9). Hypoosmotic glycine-infused with ureteral
ligation; 7.5 ml/100 g body weight of 200 mmol/liter intravenous
glycine given over 15 minutes.
Plasma was obtained one minute after infusion and two hours
post-infusion in all three groups, for measurement of electrolytes,
glucose, urea, and osmolality. At two hours, animals were sacri-
ficed as described above and brain water, sodium, and potassium
were measured.
Analytical methods
Blood pressure was measured pre-infusion and two hours
post-infusion by connecting the femoral arterial line to a trans-
ducer. Arterial blood was analyzed for partial pressure of oxygen
(Instrumentation Laboratory Model 1304 Blood Gas Analyzer,
Boston, Massachusetts, USA) and hematocrit. Plasma was ana-
lyzed for osmolality (Precision Systems Micro Osmette 5004,
Precision Systems, Natick, Massachusetts, USA) and for ammonia
concentration by a colorimetric method (Kodak Ektachem 700,
Eastman Kodak Company, Rochester, New York, USA). Plasma
and tissue sodium and potassium were measured by flame pho-
tometry (Instrumentation Laboratory 443 Flame Photometer).
High plasma levels of infused glycine (and its metabolites) or
mannitol may falsely elevate tissue levels of these solutes if the
tissue is contaminated with blood. To account for this error, brain
and gastrocnemius hemoglobin contents were determined. A 50 to
100 mg aliquot of crushed tissue was diluted with 0.01% Na2CO3
and hemoglobin was measured spectrophotometrically by the
method of Harboe [12]. The previously determined water content
of each sample was used to determine the hemoglobin concen-
tration in tissue water. Total measured tissue concentration of
solute (X) was then adjusted for plasma contamination as follows:
Actual tissue [X] = Measured tissue [X] - (Tissue [HbJ(Plasma [Hb]
X Plasma [X])
Plasma and tissue amino acids were measured by reverse-phase
HPLC as described by Gunawan, Walton and Treiman [13].
Plasma was extracted in six volumes of ice-cold 0.1 N hydrochloric
acid with 0.4 mM methionine sulfone as the internal standard, and
the extracts were centrifuged at 2,000 g for 10 minutes at 4°C. The
supernatants were then deproteinized by centrifugation through
an Ultrafree MC-10,000 NMWL filter unit (Millipore Corpora-
tion, Milford, Massachusetts, USA). Tissue was extracted by the
addition of 300 iI of ice-cold 0.1 N hydrochloric acid and 0.4 mM
methionine sulfone per 50 mg tissue, followed by vortexing for
one minute. The extracts were centrifuged and deproteinized as
described above.
Fifty microliter samples of deproteinized plasma or tissue were
derivitized with phenylisothiocyanate (Pierce Chemical Company,
Rockford, Illinois, USA) and redissolved in 200 liters of Pico-Tag
Sample Diluent (Waters Chromatography Division, Millipore
Corp.). The samples were each passed through Millex HV 0.45
.tm filters (Millipore). Samples and standard were injected onto a
Waters reverse-phase HPLC system and fractionated on a Pico-
Tag Column (Waters). The following amino acids were measured:
alanine, arginine, asparagine, aspartic acid, citrulline, gamma
amino butyric acid (GABA), glutamic acid, glycine, histidine,
hydroxy-L-proline, isoleucine, leucine, lysine, methionine, orni-
thine, phenylalanine, proline, serine, taurine, threonine, trypto-
phan, tyrosine, and valine. Levels were quantified on a Waters 840
data and chromatography control station.
Urea, mannitol and glucose concentrations were measured by
HPLC as described by Wolff et at [14]. Plasma was extracted by
addition of an equal volume 6% perchloric acid with 1% maltose
as internal standard. Tissue samples were extracted by the addi-
tion of 300 1.d of ice-cold 6% perchloric acid with 1 m maltose
per 50 mg tissue, and vortexing for one minute. The extracts were
centrifuged at 2,000 g for 10 minutes at 4°C. The resulting
supernatents were removed and neutralized with 30% potassium
hydroxide. Lipid was removed by passing the neutralized extract
though a Sep-Pak C 18 cartridge (Waters). An aliquot of 80 1 of
extract was injected into a Waters HPLC system and fractionated
on a Sugar Pak 1 column (Waters) with 0.1 mM calcium disodium
EDTA at 0.5 mI/mm and 80°C. Metabolites were detected with a
refractive index detector (Model 410, Waters). Levels were quan-
tified on a Waters 840 data and chromatography control station.
Statistics
Data are expressed as means SE. Differences between con-
currently studied groups were assessed by ANOVA using the
Scheffe-F test; differences within a group at different time points
were assessed by paired t-test. Significance levels are reported at
the P < 0.05 level.
Results
Experiment I
One animal died in each of the three groups. Mean arterial
blood pressure was >100 mm Hg both pre-infusion and two hours
post-infusion in all surviving animals.
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Table 1. Experiment I: Plasma analysis
Non-
infused
Mannitol-
infused
Glycine-
infused
Sodium mM/liter
1 mm post-infusion
2 hrs post-infusion
137 1 106 i'
108 1
111 2
120 1b,c
Osmolality mOsm/kg
1 mm post-infusion
2 hrs post-infusion
287 2 288 1
292 2
285 1
287 2
Glycine mM/liter
1 mm post-infusion
2 hrs post-infusion
0.6 0.1 0.9 0.1
1.6 0.1
44 1,b
16
Serine mM/liter
1 mm post-infusion
2 hrs post-infusion
0.5 0.1 0.4 0.1
0.5 0.1
21 2a,b
4 05b,c
Other amino acids mM/liter
1 mm post-infusion
2 hrs post-infusion
5.4 0.6 4.2 0.5
6.5 0.9c
4.3 0.2
5.7 0.4
Mannitol mM/liter
1 mm post-infusion
2 hrs post-infusion
0 58 2
52 2
0b
0b
Glucose mM/liter
1 mm post-infusion
2 hrs post-infusion
8 1 5 1
9 1
8 1"
15 l"
Urea mM/liter
1 mm post-infusion
2 hrs post-infusion
5.8 0.3 3.4 0.2
5.1 0.4c
3.9 0.9
11.0 15b,c
Ammonia ig/dl
1 mm post-infusion
2 hrs post-infusion
45 4 27 2
45 4C
202 15a,b
187 12b
P°2 mm Hg
1 mm post-infusion
2 hrs post-infusion
112 4 112 5
123 3
116 5
124 3
Hematocrit
1 mm post-infusion
2 hrs post-infusion
49 1 33 ia
39 1C
37
43 1b
P < 0.05 vs. non-infused controls
b P < 0.05 vs. mannitol-infused controls
c P < 0.05 vs. value within same group immediately post-infusion
I. Plasma values. A. Immediately after infusion with isosmotic
mannitol orglycine. Plasma sodium concentration was significantly
decreased by mannitol and glycine infusions when compared with
the non-infused controls, but plasma osmolality did not change.
Increased concentrations of plasma glycine and serine could
largely account for the "osmotic gap" noted after glycine infusion
(Table 1, Fig. 1). The measured osmotic gap in the glycine-infused
animals was 14 mOsm/kg more than the calculated osmotic gap;
the small discrepancy is not surprising considering the number of
measures summed to determine the measured gap. The combined
concentrations of other plasma amino acids did not differ in the
three experimental groups. Plasma ammonia was significantly
elevated by glycine infusion. The partial pressure of oxygen was
more than 100 mm Hg in all three groups.
B. Two hours after infusion. In the mannitol-infused group,
plasma sodium did not change significantly two hours after the
infusion was completed. In contrast, the plasma sodium rose
significantly in the glycine-infused group after two hours, indicat-
ing intracellular movement of infusate. In both mannitol- and
glycine-infused groups, plasma osmolality values two hours after
Time after infusion
Fig. 1. Measured constituents of the osmotic gap in glycine-inf used animals
at one minute and at two hours after infusion. The dashed line indicates the
calculated osmotic gap: measured osmolality - (2 X plasma sodium).
Symbols are: (U) other AA; (0) serine; (0) glycine; () urea; (•)
glucose.
infusion did not differ significantly from values obtained immedi-
ately after infusion. In glycine-infused animals, plasma serine and
glycine levels decreased significantly in comparison with values
obtained immediately after the infusion, while plasma urea and
glucose increased significantly. Changes in these solute concen-
trations could explain the changes in the osmotic gap at two hours
(Fig. 1). The combined concentrations of other amino acids did
not differ significantly between groups. Oxygenation remained
adequate in both groups of infused animals after two hours. The
hematocrit increased significantly in all infused groups after two
hours, possibly because infusate was not evenly distributed in the
extracellular fluid at one minute post-infusion.
C. Distribution of infu sate. If one assumes that all of the infusate
in the mannitol group remained in the extracellular space, an
estimate of the extracellular fluid volume (ECFV) can be made:
Pre-infusion [Na] ECFV Post-infusion [Na]. (EQ\T
+ inhusate volume)
In these studies, 7.5 mi/lOU g body weight of fluid were adminis-
tered in the mannitol- and glycine-infused groups. Assuming the
pre-infusion plasma sodium to be equivalent to non-infused
controls:
137 mmoljliter - ECFV = 106 mmolJliter . (ECFV
+ 7.5 ml/100 g body wt);
thus, ECFV = 25.6ml /100 g bodywt
Using this value for ECFV, the volume of the glycine infusate
remaining in the ECF (X) can be estimated:
Pre-infusiort [Na] 25.6 nilJlOO g body wt
= Post-infusion [Na]. (25.6 mi/lOU g body weight + X)
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Non-
infused
Mannitol-
infused
Glycine-
infused
Tissue water liter/kg thy 3.83 0.02 3.85 0.01 3.90 0.Ola
tissue wt
Sodium concentration 57 0.7 56 0.6 54 07a,b
mmol/liter tissue water
Sodium content 218 2 220 3 209 3b
mmol/kg thy tissue
Potassium concentration 128 1 129 1 124 2t
mmol/liter tissue water
Potassium content 494 3 498 5 484 5
mmol/kg thy tissue
Glycine concentration 1.1 0.1 1.1 0.1 1.4 0.1
mM/liter tissue water
Glycine content 4.1 0.2 4.2 0.2 5.2 0.7
mmol/kg thy tissue
Serine concentration 1.5 0.1 1.5 0.1 2.2 01a,b
mM/liter tissue water
Serine content 5.6 0.3 5.9 0.3 8.6 0.2al
mmol/kg thy tissue
Mannitol concentration 0 0 0
mM/liter tissue water
Urea concentration 5.3 0.8 3.9 0.4 4.2 0.5
mM/liter tissue water
Urea content 20 3 15 2 16 2
mmol/kg thy tissue
Glutamine concentration 7.0 0.3 7.5 0.3 11.7 05a,b
mM/liter tissue water
Glutamine content 26 1 29 1 45,6 2
mmol/kg thy tissue
Based on these estimates, at the end of the infusion 80% of the
glycine infusate remained in the ECF. As the serum sodium
concentration immediately post-infusion did not differ statistically
in mannitol- and glycine-infused animals, the estimated intracel-
lular movement of infused glycine at this time point is not
statistically significant. However, two hours after completion of
the infusion, only 48% of the glycine infusate remained in the
ECF (that is, over half had migrated intracellularly).
Alternatively, the ECFV can be calculated from the initial value
for plasma mannitol:
millimoles manriitol infused
plasma mannitol concentration =
ECFV + volume of mfusate
Using this value, the ECFV is calculated to be 30 mI/100 g body
weight. Based on this estimate, 56% of the glycine remained in the
ECF two hours post-infusion.
II. Tissue composition
A. Brain: (1) Water and electrolytes (Table 2). In glycine-infused
animals, brain water was 1.8% higher than in non-infused con-
trols, but not significantly different from the mannitol-infused
animals (Fig. 2). Brain sodium content was significantly lower
after glycine infusion only when compared to mannitol-infused
controls.
(2) Amino acids, urea, and mannitol. In the glycine-infused
group, brain glycine concentration and content did not differ
significantly from non-infused or mannitol-infused controls. After
glycine infusion, there was a 0.75 mM/liter increase in brain serine
Group I
Non-
infused
Group II
Mannitol-
infused
Group III
Glycine-
infused
Tissue water liter/kg thy 3.18 0.05 3.37 0.04 3.61 003a,b
tissue wt
Sodium concentration 34 1.4 35 1.0 28 O.7"
mmol/liter tissue water
Sodium content 106 4 116 4 101 3"
mmol/kg thy tissue
Potassium concentration 145 2 139 1 136 ia
mmol!liter tissue water
Potassium content 461 8 468 7 492 7
mmollkg thy tissue
Glycine concentration 6.4 0.3 7.4 0.3 18.6 1.1"
mM/liter tissue water
Glycine content 20 1 25 1 67
mmol/kg thy tissue
Serine concentration 0.9 0.1 1.0 0.1 3.3 0.2a
mM/liter
Serine content 5.6 0.3 5.9 0.3 8.6 0.2k"
mmol/kg thy tissue
Mannitol concentration 0 4.3 05a b
mM/liter tissue water
Mannitol content 0 14.7 1.7 0"
mmol/kg thy tissue
Urea concentration 9.3 0.9 9.7 0.3 14.5 l.6a
mM/liter tissue water
Urea content 30 3 33 1 47
mmol/kg thy tissue
Glutamine concentration 4.9 0.3 4.9 0.2 4.2 0.4
mM/liter tissue water
Glutamine content 15.7 1.1 16.3 0.8 15.3 1.4
mmol/kg thy tissue
a P < 0.05 vs. non-infused controls
bp < 0.05 vs. mannitol-infused controls
100
Fig. 2. Percentage change in brain and muscle tissue water in comparison to
non-infused control animals. Symbols are: (E) mannitol-infused; (U)
glycine-infused. 'P < 0.05 vs. non-infused controls; * 'P < 0.05 vs. other
groups.
Table 2. Experiment I: Brain tissue composition Table 3. Experiment I: Muscle tissue composition
a P < 0.05 vs. non-infused controls
P < 0.05 vs. mannitol-infused controls
Brain Muscie
115
110
105
0
00
0
C
ci)0
a>
a-
**
*
concentration and a 4 mM/liter increase in brain glutamine
concentration when compared to non-infused or mannitol-infused
groups. Other amino acids did not change between groups, or
differed by <0.05 mM/liter. Brain urea concentration was un-
changed following glycine infusion despite a significant increase in
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plasma urea concentration. Two hours after mannitol infusion,
mannitol was undetectable in brain.
B. Muscle: (1) Water and electrolytes (Table 3). Muscle water
content in the mannitol group was 6% higher, and in the glycine
group 13% higher than that found in the non-infused controls
(Fig. 2). Muscle sodium concentration was decreased in the
glycine group only in comparison to the mannitol group. Muscle
potassium concentration was decreased, but potassium content
was increased in glycine-infused animals in comparison to non-
infused controls.
(2) Amino acids, mannitol, and urea. In contrast to the findings
in brain tissue, muscle glycine concentration in the glycine-infused
group was more than twice that found in the other two groups.
Muscle serine in these animals was approximately three times
higher than in controls, a greater increase than that observed in
brain. In contrast to brain, muscle glutamine concentration did
not differ between groups. Other amino acids did not change
between groups, or differed by <0.05 mM/liter. After mannitol
infusion, mannitol concentration in muscle tissue water was 8.5%
that of plasma. Muscle urea concentration was increased in the
glycine-infused group, in concert with the elevated plasma urea in
this group.
Experiment II
(1.) Plasma values (Table 4). Immediately after infusion of
hypoosmotic glycine, plasma sodium decreased more in anuric
animals than in animals without prior ureteral ligation (PC). This
suggests that a substantial osmotic diuresis may have occurred
within the 15-minute infusion period. After two hours, the plasma
sodium in both infused groups increased, consistent with move-
ment of glycine to the intracellular space as observed in Experi-
ment I. By two hours, plasma glucose and urea, both metabolites
of glycine, had increased slightly in both infused groups, but the
change was statistically significant only in anuric animals. Despite
the low osmolality of the infusate, plasma osmolality was only
slightly lower than controls in both glycine-infused groups.
(2.) Brain constituents (Table 4). Brain water did not differ
significantly between groups, though it trended higher in anuric
animals infused with glycine, similar to results in Experiment I.
Brain sodium content was significantly lower in both infused
groups.
Discussion
The fluid used to irrigate the operative field during TURP must
be electrolyte-free. Several liters of irrigant may be absorbed
through the prostatic venous plexus and/or the perforated pros-
tatic capsule [15]. Originally, distilled water was used as irrigant,
but it caused intravascular hemolysis. To avoid hemolysis, isos-
motic to slightly hypoosmotic solutions of mannitol, sorbitol or
glycine are now utilized.
Mannitol is inert and causes no neurologic complications
despite severe hyponatremia [16]. Sorbitol, available as a slightly
hypoosmotic solution (3.3% or 180 mOsm/kg), is rapidly metab-
olized to fructose and glucose and then to CO2 and water. The
mean half-life of sorbitol in plasma after TURP is approximately
20 minutes [171. Thus, compared to mannitol, sorbitol solutions
have less potential for extravascular volume overload, but a higher
risk for hypoosmolality and cerebral edema. Glycine has a longer
half-life in plasma than sorbitol, averaging 85 minutes in patients
Table 4. Experiment II: Plasma and brain compostion
Group II Group III
Group I Hyposmotic Hypoosmotic
Non- glycine- glycine-
infused— infused—no infused—
prior prior prior
ureteral ureteral ureteral
ligation ligation ligation
Plasma sodium mM/liter
1 mm post-infusion
2 hrs post-infusion
141 ia
139 ia
124 3
129 ia
115 ia
126 1a.1
Plasma osmolality
mOsm/kg
1 mm post-infusion 297 3 294 4 287 4
2 hrs post-infusion 298 4 293 4 295 3
Plasma glucose mM/liter
1 mm post-infusion
2 hrs post-infusion
6.3 0.4
9.3 0.8"
6.1 0.6
10.8 07h
5.6 0.3
12.1 0.6I,C
Plasma urea mM/liter
1 mm post-infusion
2 hrs post-infusion
6.9 0.7
9.5 0.8"
6.5 0.3
11.7 10b
6.8 0.3
13.6
Brain water liter/kg dry 3.83 0.02 3.83 0.03 3.88 0.02
tissue wt
Brain sodium
concentration
mmol/liter tissue water 52 P 49 1 48 1
Brain sodium content 200 2 186 2 186 2
mmol/kg thy tissue
Brain potassium 124 1 121 2 121 2
concentration mmol/
liter tissue water
Brain potassium content 475 4 462 7 468 7
mmol/kg dry tissue
a P < 0.05 vs. other groups
bP < 0.05 vs. value within same group immediately post-infusion
P < 0.05 vs. non-infused animals
after TURP [18]. It is the most commonly used irrigant for TURP,
and is also the agent most commonly associated with PPS.
Our animal model investigates whether the acute hyponatremia
caused by absorbed glycine irrigant is associated with correspond-
ingly severe hypoosmolality, and more importantly, whether it
contributes directly to the pathogenesis of this syndrome by
causing cerebral edema. In our model, plasma concentrations of
glycine and its metabolites, serine, urea and glucose, increased
markedly, thereby maintaining a constant plasma osmolality de-
spite hyponatremia. Maintenance of plasma osmolality with isos-
motic glycine infusion has also been observed in an animal model
of PPS in sheep with unrestricted urine output [10]. Similarly, in
a clinical study of five patients who developed PPS after under-
going TURP with isosmotic (2.2%) glycine irrigant, plasma osmo-
lality decreased by only 1 mOsm/kg despite an 18 mmol/liter
decrease in serum sodium concentration [19] .These data suggest
that hyponatremia due to isosmotic glycine irrigant does not result
in correspondingly severe hypoosmolality.
Immediately after infusion, glycine, like mannitol, was distrib-
uted primarily in the ECF. Two hours later, about half of the
infused glycine had migrated intracellularly, expanding the pro-
portionally larger intracellular space of muscle and increasing its
water content and tissue glycine concentration [20]. Increased
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muscle glycine has also been documented in humans who have
undergone TURP with glycine irrigant [21].
Despite maintenance of isosmolality, glycine infusion could
potentially cause cerebral edema if the infusate entered brain like
it entered muscle. However, our studies show the brain to be
largely spared from intracellular movement of glycine. This
finding is consistent with studies of amino acid transport across
the blood-brain barrier. Three transport systems for neutral, basic,
and acidic amino acids have been identified in the luminal
membranes of brain capillaries [22]. However, glycine does not
appear to have a selective carrier system for penetration across
the blood-brain barrier and has a low uptake into brain compared
to other amino acids [22, 23]. In addition, there appears to be a
carrier on the antiluminal surface of brain capillaries that trans-
ports glycine from brain to blood [24]. Thus, the CSF to plasma
glycine concentration ratio (0.02) is significantly lower than that of
other amino acids [25]. Consistent with the limited movement of
glycine across the blood-brain barrier, brain water increased by
only 1.8% in the glycine-infused animals, a change that was
significant when compared to non-infused control animals, but not
significant when compared to mannitol-infused controls (Fig. 2).
This small increase in brain water was associated with a slight
decrease in brain sodium content, a known "compensatory"
response to cerebral edema [26, 27]. This finding provides indirect
evidence that a small increase in brain water did indeed occur. In
glycine-infused animals, plasma sodium concentration fell to 111
mmol/liter within 15 minutes. From previous studies, at least a 5
to 10% increase in brain water would be expected if hyponatremia
of this magnitude were induced by water intoxication [26—28]. In
addition, one would predict a high mortality if the plasma sodium
were lowered by 30 mmol/liter over 15 minutes due to water
intoxication [28], but the survival of glycine-infused animals in our
study was no different than controls.
Hyponatremia caused by systemically-absorbed glycine has
sometimes been equated to hyponatremia from water intoxica-
tion. For example, men with PPS were recently used as case-
matched controls for females who died from postoperative water
intoxication [29]. The benignity of severe hyponatremia in males
with PPS was offered as proof that females are less tolerant of
acute hyponatremia than males are. However, the observations
above suggest that severe hyponatremia observed in PPS associ-
ated with glycine irrigant does not result in correspondingly severe
hypoosmolality, and does not cause the cerebral edema that would
be expected with water intoxication of an equivalent magnitude.
The minimal brain edema observed in our studies despite
severe acute hyponatremia suggests that cerebral edema induced
by hyponatremia is not the primary cause of PPS. Toxicity from
glycine or its metabolites, rather than hyponatremia, may contrib-
ute to the pathogenesis of syndrome. Glycine is a major inhibitory
neurotransmitter in mammalian brain [30]. It is also an inhibitory
transmitter in the retina and decreases ocular-evoked potentials
[31]. Visual hallucinations and blindness are common immedi-
ately after TURP with glycine irrigant and may occur in the
absence of significant hyponatremia [32].
Metabolites of glycine include serine, urea, glucose, glyoxalate
and ammonia. Ammonia levels in PPS have correlated with
symptoms of PPS in some, but not all studies [33—35]. In brain,
ammonia is metabolized by glutamine synthetase, located mainly
in astrocytes [36]. In our studies, plasma ammonia increased in
glycine-infused animals and there was a 4 m increase in brain
Non-infused Mannitol- Glycine-
infused infused
Fig. 3. Brain content of glutamine () and other amino acids (LI),
expressed in mmol!kg thy brain tissue weight. *p < 0.05 vs. other groups.
glutamine concentration. The increase in brain glutamine ac-
counted for almost all of the increased brain total amino acid
content in the glycine-infused group (Fig. 3). In previous studies
of hyperammonemic animals, brain glutamine correlates with
brain water content, suggesting that brain edema during hyper-
ammonemia is caused by the osmotic effect of increased brain
glutamine [37]. Hyperammonemia and a subsequent increase in
brain glutamine may also have contributed to the small increase in
brain water that we observed.
Our results indicate that even when hypotonic glycine is infused
(analogous to absorption of 1.5% glycine in clinical practice),
plasma osmolality decreases only slightly for the degree of hy-
ponatremia induced. This is consistent with several clinical stud-
ies. Ghanem and Ward prospectively studied a group of 100
patients exposed to 1.5% glycine irrigant, of whom 10 developed
PPS [38]. In these 10 patients, the serum sodium decreased by an
average of 17.7 mmol/liter, which would be expected to decrease
the serum osmolality by 35 mOsm/kg. However, the observed
serum osmolality decreased by only 11.4 mOsm/kg. Similarly,
Wang found an average decrease in plasma osmolality of only 6
mOsm/liter, despite a 16 mmol/liter decrease in plasma sodium
[31]. These findings, as well as those in the present study, are
predictable. Consider a 70 kg man who absorbs 5 liters of a 1.5%
(200 mOsm/kg) glycine solution (approximately equivalent to the
amount of infusate administered to animals in the present study).
Assuming preoperative plasma sodium and osmolality values of
145 mmol/liter and 290 mOsmlkg and an initial distribution
volume (ECF) of 14 liters, the plasma sodium would be expected
to decrease to 113 mmol/liter and the plasma osmolality to 280
mOsm/kg. After absorption of 5 liters of an isosniotic (290
mOsm/kg) glycine solution, plasma osmolality would be expected
to be 290 mOsm/kg and plasma sodium 107 mmol/liter.
In summary, acute hyponatremia induced by isosmotic glycine
infusion was associated with a normal plasma osmolality over the
two-hour time course of our studies. Infused glycirie moved
intracellularly to a large extent, and muscle water and glycine
content increased significantly. However, brain water increased
minimally, and brain glycine content did not change. Infusion of
200 mmol/liter glycine had similar effects on brain water. Our
studies indicate that the hyponatremia observed in PPS associated
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with glycine irrigant is not comparable to hyponatremia due to
water intoxication.
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